Anika Therapeutics ANIK Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Commercial Channel | $48.41M+14.9% | $42.14M+16.6% | $36.15M+12.4% | $32.15M— | |
| OEM Channel | $64.41M-17.2% | $77.77M-8.1% | $84.65M+3.6% | $81.68M— | |
| Percentage Of Net Revenue by Product | |||||
| Commercial Channel | 43%+8.0pp | 35%+5.0pp | 30%+2.0pp | 28%— | |
| OEM Channel | 57%-8.0pp | 65%-5.0pp | 70%-2.0pp | 72%— | |
| Revenue by Geography | |||||
| Europe | $22.21M+14.5% | $19.4M+12.1% | $17.31M+0.5% | $17.23M-12.0% | |
| Other Location | $20.55M+13.8% | $18.06M+9.0% | $16.57M+26.6% | $13.09M-9.0% | |
| US | $70.14M-15.0% | $82.47M-9.4% | $90.99M+3.9% | $87.55M-23.1% | |
| Percentage Of Net Revenue by Geography | |||||
| Other Location | 53%— | —— | 40%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Anika Therapeutics break its business down?
- Anika Therapeutics (ANIK) reports revenue by product across 2 parts — Commercial Channel and OEM Channel. Each is extracted from the segment footnotes and tracked over time.
- Where does Anika Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Anika Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
